Here’s some good news for value investors: FibroGen, Inc. (FGEN), Newmont Goldcorp Corporation (NEM) – Post Analyst

This post was originally published on this site

Here’s some good news for value investors: FibroGen, Inc. (FGEN), Newmont Goldcorp Corporation (NEM)  Post Analyst

FibroGen, Inc. (NASDAQ:FGEN) is expensive when one looks at the company’s price to sales ratio of 15.92 and compares it with other companies in the …

This post was originally published on *this site*